Archive for the 'Industry News Alerts' Category
April 1st, 2011 by admin
In what could be the biggest breakthrough in the treatment of one of the deadliest cancer types, researchers at the University of East Anglia (UEA) and Children’s Hospital Boston have unveiled an effective new treatment for treating melanoma skin cancer.
Continue reading ‘Arthritis Drug to Combat Melanoma Skin Cancer’
March 21st, 2011 by admin
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process are called substrates, and they are converted into different molecules, called the products. Almost all processes in a biological cell need enzymes to occur at significant rates. Since enzymes are selective for their substrates and speed up only a few reactions from among many possibilities, the set of enzymes made in a cell determines which metabolic pathways occur in that cell.
Continue reading ‘Biotech for Enzymes: Protein Engineering’
March 14th, 2011 by admin
A new study has shown that children who grow up in urban areas are more likely to suffer from asthma as compared to children who grow up on farms. Dr. Markus Ege and Professor Erika von Mutius at Ludwig-Maximilians-Universitaet (LMU) along with an international team of researchers have recently published a large-scale study that proves that this phenomenon is probably due to the differences in the range of bacteria and microbes children encounter. Their research findings also indicate that some types of microorganisms may also have the ability to offer protection against asthma.
Continue reading ‘Protection against Asthma through Bacteria and Fungi’
March 4th, 2011 by admin
It looks as if user fees really are in the offing for generic drugs. After generics makers said last week that they’re supporting the idea as a way to speed approvals of their products, FDA Commissioner Margaret Hamburg backed it, too. Revamping the current approvals process is “critical,” she said, because agency funding won’t provide the resources to clear the backlog of apps.
Continue reading ‘Generic Fees Gain Traction with FDA Backing’
March 4th, 2011 by admin
Fast Company has surveyed the biotech world and come up with its list of the Top 10 companies in the industry. Amyris makes the list for its work combating the malaria parasite, while Galapagos and Fate Therapeutics get nods for pipeline innovation.
Continue reading ‘Fast Company Highlights 10 Top Innovators in Biotech’
March 3rd, 2011 by admin
Medco Health Solutions Inc’s (MHS.N) quarterly profit rose 11 percent on increased mail deliveries of generic drugs, but its shares fell as the report failed to excite investors. The U.S. pharmacy benefit manager reported a fourth-quarter profit, excluding special items, that matched Wall Street’s target and it backed its 2011 forecast. Its shares fell 4.5 percent.
Continue reading ‘Medco in-line Profit Report Fails to Excite Market’
March 3rd, 2011 by admin
U.S. medical researchers are using modified printers to produce skin for burn victims, the project’s leader says. “We started out by taking a typical desktop inkjet cartridge. Instead of ink we use cells, which are placed in the cartridge,” Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine in Winston-Salem, N.C., told CNN.
Continue reading ‘Printers Used to Produce Human Skin?’
March 2nd, 2011 by admin
Two U.S. senators have revived the reimportation debate with a new bill co-sponsored by a bipartisan group of their fellows. Sen. Debbie Stabenow (D-Michigan) is teaming up with Sen. Olympia Snowe (R-Maine) on the proposal, which would allow U.S. pharmacies and drug wholesalers to source products from other countries with “tough safety standards.”
Continue reading ‘Senators Resurrect Reimportation with New Bill’
February 28th, 2011 by admin
MedTrust Online and Avantra Biosciences have entered into a partnership to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences’ revolutionary QPDx multiplex immunoassay system.
Continue reading ‘MedTrust, Avantra Partner to Develop Biomarker Assays for Cancer’
February 23rd, 2011 by admin
Pharmaceutical companies in India are growing at a very fast pace and this has made the Indian pharmaceutical industry as the second largest growing industry. Also the pharmaceutical industry in India is the third largest in the world, which will be of US$20 billion by 2015. Mergers and acquisitions are the part of this growth. The compounded annual growth rate of pharma in India is 12-15% and the global figures are 4-7% for the period of 2008-2013. With such a profound growth of pharmaceutical companies in India numerous pharmaceutical jobs can be seen. This in turn is helping biotechnology industry and booming the biotechnology jobs in India.
Continue reading ‘Pharmaceutical Industry in India, Top Pharma Companies and Jobs’